Vapotherm (VAPO) plans to raise $60 million in an initial public offering (IPO) on Wednesday, November 14th, IPO Scoop reports. The company will be issuing 4,000,000 shares at a price of $14.00-$16.00 per share.
In the last year, Vapotherm generated $41.1 million in revenue and had a net loss of $38.6 million. The company has a market cap of $249.7 million.
BofA Merrill Lynch and William Blair served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.
Vapotherm provided the following description of their company for its IPO: ” We are a global medical technology company focused on the development and commercialization of our proprietary Hi-VNI Technology products that are used to treat patients of all ages suffering from respiratory distress. Our Hi-VNI Technology delivers noninvasive ventilatory support by providing heated, humidified and oxygenated air at a high velocity to patients through a comfortable small-bore nasal interface. Our Precision Flow systems, which use Hi-VNI Technology, are clinically validated alternatives to, and address many limitations of, the current standard of care for the treatment of respiratory distress in a hospital setting. As of September 30, 2018, more than 1.5 million patients have been treated with our Precision Flow systems, and we have a global installed base of over 12,000 capital units. “.
Vapotherm was founded in 1999 and has 298 employees. The company is located at 100 Domain Drive, Exeter, NH 03833, US and can be reached via phone at (866) 410-9986 or on the web at http://www.vapotherm.com.
Receive News & Ratings for Vapotherm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vapotherm and related companies with MarketBeat.com's FREE daily email newsletter.